Literature DB >> 10395079

Mechanisms of resistance to pathogenesis in muscular dystrophies.

J P Infante1, V A Huszagh.   

Abstract

A mechanistic definition of the dystrophic process is proposed, and the effects of growth factors vs. down-regulation of growth are critically analyzed. A conceptual scheme is presented to illustrate the steps leading to pathology, and various compensatory systems which ameliorate the pathology are examined, particularly in regards to the mdv mouse which is resistant to the deficiency of dystrophin, the main protein product of the Duchenne and Becker muscular dystrophy (DMD/BMD) gene. These compensatory systems are analyzed in terms of the differential resistance of fiber types to pathogenesis. The generation of a stable population of maturationally arrested centronucleated fibers which express the mature adult myosin isoforms is proposed to be the main strategy of mdx muscle to minimize apoptosis. Physiological properties of these fibers, such as utrophin expression, and high mitochondrial and endoplasmic reticulum content, together with probable increased glycerophosphorylcholine concentrations and facile access to the vascular system, are hypothesized to be instrumental in their resistance to pathogenesis. It is proposed that the major element that determines the susceptibility of most human muscles to the dystrophic process is their inability to arrest the maturation of regenerated fibers at the centronucleated stage with a concomitant expression of the adult myosins.

Entities:  

Mesh:

Year:  1999        PMID: 10395079     DOI: 10.1023/a:1006972315739

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  159 in total

1.  [Degeneration and regeneration of striated skeletal muscle fibers in Duchenne muscular dystrophy].

Authors:  G Brasseur; J P Onolfo; H Copin; F Leperchey; J P Barbet
Journal:  Morphologie       Date:  1997-03

2.  Involvement of the nervous system in muscular dystrophies in man.

Authors:  V Dubowitz
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

3.  Progressive deterioration of muscles in mdx mice induced by overload.

Authors:  J Dick; G Vrbová
Journal:  Clin Sci (Lond)       Date:  1993-02       Impact factor: 6.124

4.  Cross-talk between transcriptional regulation by thyroid hormone and myogenin: new aspects of the Ca2+-dependent expression of the fast-type sarcoplasmic reticulum Ca2+-ATPase.

Authors:  M H Thelen; W S Simonides; A Muller; C van Hardeveld
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

5.  Prognostic factors in mild dystrophinopathies.

Authors:  C Angelini; M Fanin; M P Freda; F Martinello; M Miorin; P Melacini; G Siciliano; E Pegoraro; M Rosa; G A Danieli
Journal:  J Neurol Sci       Date:  1996-10       Impact factor: 3.181

6.  Creatine kinase isoenzyme profiles after exercise in the rat: sex-linked differences in leakage of CK-MM.

Authors:  G J Amelink; H H Kamp; P R Bär
Journal:  Pflugers Arch       Date:  1988-09       Impact factor: 3.657

7.  The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related.

Authors:  J Taylor; F Muntoni; V Dubowitz; C A Sewry
Journal:  Neuropathol Appl Neurobiol       Date:  1997-10       Impact factor: 8.090

8.  Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.

Authors:  T Miike
Journal:  Muscle Nerve       Date:  1983-10       Impact factor: 3.217

9.  Absence of correlation between utrophin localization and quantity and the clinical severity in Duchenne/Becker dystrophies.

Authors:  M Vainzof; M R Passos-Bueno; N Man; M Zatz
Journal:  Am J Med Genet       Date:  1995-09-25

10.  Canine X-linked muscular dystrophy: morphologic lesions.

Authors:  B A Valentine; B J Cooper; J F Cummings; A de Lahunta
Journal:  J Neurol Sci       Date:  1990-06       Impact factor: 3.181

View more
  9 in total

1.  Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.

Authors:  Yetrib Hathout; Ramya L Marathi; Sree Rayavarapu; Aiping Zhang; Kristy J Brown; Haeri Seol; Heather Gordish-Dressman; Sebahattin Cirak; Luca Bello; Kanneboyina Nagaraju; Terry Partridge; Eric P Hoffman; Shin'ichi Takeda; Jean K Mah; Erik Henricson; Craig McDonald
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

2.  Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gamma production.

Authors:  Jussara Lagrota-Candido; Rita Vasconcellos; Marta Cavalcanti; Marcelo Bozza; Wilson Savino; Thereza Quirico-Santos
Journal:  Int J Exp Pathol       Date:  2002-06       Impact factor: 1.925

3.  Functional muscle analysis of the Tcap knockout mouse.

Authors:  C D Markert; M P Meaney; K A Voelker; R W Grange; H W Dalley; J K Cann; M Ahmed; B Bishwokarma; S J Walker; S X Yu; M Brown; M W Lawlor; A H Beggs; M K Childers
Journal:  Hum Mol Genet       Date:  2010-03-16       Impact factor: 6.150

4.  Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.

Authors:  Shu-Ching Huang; Anyu Zhou; Dan T Nguyen; Henry S Zhang; Edward J Benz
Journal:  J Biol Chem       Date:  2016-10-25       Impact factor: 5.157

5.  Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

Authors:  Christian Isaac; Adam Wright; Arvydas Usas; Hongshuai Li; Ying Tang; Xiaodong Mu; Nicholas Greco; Qing Dong; Nam Vo; James Kang; Bing Wang; Johnny Huard
Journal:  J Orthop Res       Date:  2012-10-23       Impact factor: 3.494

6.  Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice.

Authors:  Maria Cristina Salimena; Jussara Lagrota-Candido; Thereza Quírico-Santos
Journal:  Histochem Cell Biol       Date:  2004-09-28       Impact factor: 4.304

7.  Muscle metabolic remodelling patterns in Duchenne muscular dystrophy revealed by ultra-high-resolution mass spectrometry imaging.

Authors:  Ivana Dabaj; Justine Ferey; Florent Marguet; Vianney Gilard; Carole Basset; Youssef Bahri; Anne-Claire Brehin; Catherine Vanhulle; France Leturcq; Stéphane Marret; Annie Laquerrière; Isabelle Schmitz-Afonso; Carlos Afonso; Soumeya Bekri; Abdellah Tebani
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

8.  Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients.

Authors:  Chiara Marchesi; Marzia Belicchi; Mirella Meregalli; Andrea Farini; Alessandra Cattaneo; Daniele Parolini; Manuela Gavina; Laura Porretti; Maria Grazia D'Angelo; Nereo Bresolin; Giulio Cossu; Yvan Torrente
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

9.  Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects.

Authors:  Glen B Banks; Jeffrey S Chamberlain; Guy L Odom
Journal:  PLoS Genet       Date:  2020-11-11       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.